- Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancerRoperch Jean Pierre; Grandchamp Bernard; Desgrandchamps Francois; Mongiat Artus Pierre; Ravery Vincent; Ouzaid Idir; Roupret Morgan; Phe Veronique; Ciofu Calin; Tubach Florence; Cussenot Olivier; Incitti RobertoBMC Cancer, 2016, 16: 704.被引 45
- UriFind Assay Facilitates the Management of Urothelial Carcinoma in a Large-Scale Multicenter Prospective CohortBibikova, M.; Wang, H.; Chen, X.; Liu, Z.; Zhou, L.; Fan, J.; Lv, Q.; Wei, Q.; Chen, H.; Xu, T.; Li, L.; Wang, S.; Tan, W.; Xu, A.; Yang, J.; Zhong, J.; Ruan, W.; Chen, Z.; Fan, J.; Huang, J.; Lin, T.Annual Meeting of the Association-for-Molecular-Pathology (AMP), Salt Lake City, UT, 2023-11-14 To 2023-11-18.
- Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancersManuel Caitano Maia; Meghan Salgia; Sumanta K. PalNature Reviews Urology, 2020, 17(Suppl. 8).
期刊论文
Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder Cancer
27阅读
